Description
Pimobendan
CAS No.: 74150-27-9
Molecular Formula: C₁₉H₁₈N₂O₂
Molecular Weight: 306.36
EINECS No.: Not available
Related Categories: Cardiotonics; Phosphodiesterase III Inhibitors; Calcium Sensitizers; Veterinary Pharmaceuticals
Use: Management of mild, moderate, or severe congestive heart failure (CHF) due to myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM) in dogs
Description: Pimobendan is a benzimidazole-pyridazinone derivative with dual mechanisms: it sensitizes cardiac troponin C to calcium (enhancing contractility without increasing oxygen demand) and inhibits phosphodiesterase III (causing vasodilation). This “inodilator” effect improves stroke volume, reduces preload and afterload, and prolongs survival in dogs with CHF. It is administered orally twice daily and is often used alongside furosemide, ACE inhibitors, and spironolactone in standard heart failure protocols.
- Pimobendan
- C19H18N4O2
- 640-420-7
Production Capacity:
302
Delivery Timeframe:
Immediate
Incoterms:
CFR - Cost and Freight
CIF - Cost, Insurance and Freight
CIP - Carriage and Insurance Paid to
EXW - Ex Works
FAS - Free Along Ship
FCA - Free Carrier
FOB - Free on Board
Packaging Details:
25kg/Fiber Drum
More about
Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
50-100
Employees
100K - 200K
Sales volume (USD)
90%
% Export sales
Year
Established
Business type
- Industry / Manufacturer
- Representative / Agent
- Distributor / Wholesaler
- Business Service
Keywords
- APIs
- intermediates
- Peptide
- Insulin
Contact and location
-
Kimbo ********
-
+86 1********
-
Jianggan Area / Zhejiang | China